Correction: VersicanV1 promotes proliferation and metastasis of hepatocellular carcinoma through the activation of EGFR–PI3K–AKT pathway (Oncogene, (2018), 37, 41, (5585-5586), 10.1038/s41388-018-0495-6)

D. Elias*, Henriette Vever, A. V. Lænkholm, M. F. Gjerstorff, C. W. Yde, A. E. Lykkesfeldt, H. J. Ditzel

*Kontaktforfatter

Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

26 Downloads (Pure)

Abstrakt

Since the publication of this Erratum, the Authors noticed a further error in Fig. 1c. The same image was inserted twice next to each other (second row: PRKCA, image for RamR7 and TamR8) instead of the correct image for TamR8. The corrected Fig. 1c has been provided below.

OriginalsprogEngelsk
TidsskriftOncogene
Vol/bind39
Udgave nummer10
Sider (fra-til)2229-2230
ISSN0950-9232
DOI
StatusUdgivet - mar. 2020

Fingeraftryk

Dyk ned i forskningsemnerne om 'Correction: VersicanV1 promotes proliferation and metastasis of hepatocellular carcinoma through the activation of EGFR–PI3K–AKT pathway (Oncogene, (2018), 37, 41, (5585-5586), 10.1038/s41388-018-0495-6)'. Sammen danner de et unikt fingeraftryk.

Citationsformater